BMI 0 3 0 3 B-bmi
( 4 5 4 5 O
within 5 11 5 11 O
10 12 14 12 14 B-upper_bound
% 14 15 14 15 I-upper_bound
) 15 16 15 16 O

Contraindications 0 17 17 34 O
to 18 20 35 37 O
SPECT 21 26 38 43 B-treatment
/ 26 27 43 44 O
CT 27 29 44 46 O
, 29 30 46 47 O
pregnancy 31 40 48 57 B-pregnancy
, 40 41 57 58 O
breastfeeding 42 55 59 72 O
, 55 56 72 73 O
chronic 57 64 74 81 B-chronic_disease
renal 65 70 82 87 I-chronic_disease
disease 71 78 88 95 I-chronic_disease
( 79 80 96 97 O
eGFR 80 84 97 101 B-clinical_variable
< 85 86 102 103 O
60 87 89 104 106 B-upper_bound
ml 90 92 107 109 I-upper_bound
/ 92 93 109 110 I-upper_bound
min/1.73m2 93 103 110 120 I-upper_bound
) 103 104 120 121 O
, 104 105 121 122 O
proteinuria 106 117 123 134 B-treatment
, 117 118 134 135 O
genetic 119 126 136 143 B-treatment
diseases 127 135 144 152 I-treatment
of 136 138 153 155 I-treatment
the 139 142 156 159 I-treatment
kidney 143 149 160 166 I-treatment
, 149 150 166 167 O
inborn 151 157 168 174 O
defects 158 165 175 182 O
of 166 168 183 185 O
lipid 169 174 186 191 B-chronic_disease
metabolism 175 185 192 202 I-chronic_disease
, 185 186 202 203 O
alcohol 187 194 204 211 O
abuse 195 200 212 217 O
, 200 201 217 218 O
liver 202 207 219 224 B-chronic_disease
disease 208 215 225 232 I-chronic_disease
( 216 217 233 234 O
patients 217 225 234 242 O
with 226 230 243 247 O
highly 231 237 248 254 O
elevated 238 246 255 263 O
total 247 252 264 269 B-clinical_variable
bilirubin 253 262 270 279 I-clinical_variable
, 262 263 279 280 O
elevated 264 272 281 289 O
liver 273 278 290 295 O
enzymes 279 286 296 303 O
AST 287 290 304 307 B-clinical_variable
, 290 291 307 308 O
ALT 292 295 309 312 B-clinical_variable
and 296 299 313 316 O
alkaline 300 308 317 325 B-clinical_variable
phosphatase 309 320 326 337 I-clinical_variable
and 321 324 338 341 O
those 325 330 342 347 O
with 331 335 348 352 O
an 336 338 353 355 O
established 339 350 356 367 O
liver 351 356 368 373 O
disease 357 364 374 381 O
) 364 365 381 382 O
, 365 366 382 383 O
anemia 367 373 384 390 B-chronic_disease
, 373 374 390 391 O
and 375 378 392 395 O
pharmacological 379 394 396 411 B-treatment
treatment 395 404 412 421 I-treatment
with 405 409 422 426 I-treatment
insulin 410 417 427 434 I-treatment
or 418 420 435 437 I-treatment
insulin 421 428 438 445 I-treatment
- 428 429 445 446 I-treatment
sensitizing 429 440 446 457 I-treatment
drugs 441 446 458 463 I-treatment
such 447 451 464 468 O
as 452 454 469 471 O
thiazolidinediones 455 473 472 490 B-treatment
( 474 475 491 492 I-treatment
TZD 475 478 492 495 I-treatment
) 478 479 495 496 I-treatment

In 0 2 497 499 O
the 3 6 500 503 O
Control 7 14 504 511 O
group 15 20 512 517 O
( 21 22 518 519 O
N=10 22 26 519 523 O
) 26 27 523 524 O
, 27 28 524 525 O
we 29 31 526 528 O
will 32 36 529 533 O
include 37 44 534 541 O
volunteers 45 55 542 552 O
with 56 60 553 557 O
no 61 63 558 560 O
history 64 71 561 568 O
of 72 74 569 571 O
stone 75 80 572 577 B-chronic_disease
disease 81 88 578 585 I-chronic_disease
matched 89 96 586 593 O
for 97 100 594 597 O
age 101 104 598 601 B-age
( 105 106 602 603 O
within 106 112 603 609 O
5 113 114 610 611 B-upper_bound
years 115 120 612 617 I-upper_bound
) 120 121 617 618 O

age 0 3 619 622 B-age
> 4 5 623 624 O
21 6 8 625 627 B-lower_bound
years 9 14 628 633 I-lower_bound

diabetes 0 8 634 642 B-chronic_disease
status 9 15 643 649 O

